OTC Markets OTCPK - Delayed Quote USD

Fuse Medical, Inc. (FZMD)

Compare
0.0500 0.0000 (0.00%)
At close: October 24 at 4:00 PM EDT
Loading Chart for FZMD
DELL
  • Previous Close 0.0000
  • Open 0.0460
  • Bid 0.0130 x --
  • Ask 0.0800 x --
  • Day's Range 0.0460 - 0.0460
  • 52 Week Range 0.0460 - 0.1700
  • Volume 4,347
  • Avg. Volume 232
  • Market Cap (intraday) 3.695M
  • Beta (5Y Monthly) -1.05
  • PE Ratio (TTM) 1.00
  • EPS (TTM) 0.0500
  • Earnings Date Sep 5, 2024 - Sep 6, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Fuse Medical, Inc. manufactures and distributes medical devices in the United States. The company offers orthopedic implants, including internal and external fixation products for foot and ankle; upper and lower extremity plating and total joint reconstruction implants; soft tissue fixation and augmentation for sports medicine procedures; and full spinal implants for trauma, degenerative disc disease, and deformity indications. It also provides osteo-biologics and regenerative products, which include human allografts, tendons, synthetic skin and bone substitute materials, and regenerative tissues. The company serves hospitals, medical facilities, and sub-distributors. Fuse Medical, Inc. is based in Richardson, Texas.

www.fusemedical.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: FZMD

View More

Performance Overview: FZMD

Trailing total returns as of 10/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

FZMD
58.33%
S&P 500
21.80%

1-Year Return

FZMD
70.59%
S&P 500
37.77%

3-Year Return

FZMD
93.51%
S&P 500
27.83%

5-Year Return

FZMD
85.71%
S&P 500
93.37%

Compare To: FZMD

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: FZMD

View More

Valuation Measures

Annual
As of 10/24/2024
  • Market Cap

    3.33M

  • Enterprise Value

    5.29M

  • Trailing P/E

    0.88

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.20

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    0.29

  • Enterprise Value/EBITDA

    1.22

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    21.61%

  • Return on Assets (ttm)

    0.35%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    18.4M

  • Net Income Avi to Common (ttm)

    3.98M

  • Diluted EPS (ttm)

    0.0500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    253.38k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    1.04M

Research Analysis: FZMD

View More

Company Insights: FZMD

Research Reports: FZMD

View More

People Also Watch